Sylke Hassel

Sylke Hassel is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Chief Executive Officer at Axplora since October 2022, Sylke has held CEO positions at Novasep and PharmaZell Group, as well as leadership roles at Lonza, Sandoz International GmbH, and McKinsey. Sylke's educational background includes a Master of Science in Biology/Biochemistry from The Julius Maximilians University of Würzburg, where the focus was on cell biology, virology, and immunology. Sylke's career reflects a strong commitment to advancing biopharmaceutical innovation and strategy.